Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26626534 | 0.97 | KDM4E (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL25833656 | 0.95 | KDM4E (0.35) | KDM4EATML3MBTL1ABCG2 | |
| SCHEMBL19074850 | 0.95 | L3MBTL1 (0.36) | KDM4EATML3MBTL1ABCG2KMT2A | |
| SCHEMBL13466229 | 0.93 | L3MBTL1 (0.36) | KDM4EATML3MBTL1ABCG2KMT2A | |
| SCHEMBL19507831 | 0.90 | KDM4E (0.38) | KDM4EATML3MBTL1ABCG2 | |
| SCHEMBL19849214 | 0.89 | — | — | |
| SCHEMBL21345442 | 0.88 | MAPT (0.33) | KDM4EATML3MBTL1ABCG2KMT2A | |
| SCHEMBL21734479 | 0.88 | L3MBTL1 (0.44) | KDM4EATML3MBTL1KMT2AIL1R1 | |
| SCHEMBL26807980 | 0.87 | KDM4E (0.38) | KDM4EATML3MBTL1ABCG2KMT2A | |
| SCHEMBL19076296 | 0.87 | NQO2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12030894-B2 | Composition for organic optoelectronic device, organic optoelectronic device and display device | SAMSUNG SDI CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12030894-B2 | Composition for organic optoelectronic device, organic optoelectronic device and display device | OR10J3, OCIAD2, OCIAD1 | KDM4E 4422/4885ATM 4252/4885L3MBTL1 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.